Silencing of the TGF-β1 Gene Increases the Immunogenicity of Cells From Human Ovarian Carcinoma
Journal of immunotherapy (Hagerstown, Md. : 1997) - United States
doi 10.1097/cji.0b013e31824d72ee
Full Text
Open PDFAbstract
Available in full text
Date
April 1, 2012
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)